Literature DB >> 7083761

Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.

P Hillon, L Blanchet, D Lebrec.   

Abstract

1. The effects of propranolol on heart rate, arterial pressure, portal venous pressure and fractional hepatic blood flow were studied in rats with hepatic artery ligature or with portal vein stenosis, and in sham-operated rats. The effect of propranolol on cardiac output was also studied in normal rats. 2. In rats with hepatic artery ligature or with portal vein stenosis, and in sham-operated rats, propranolol decreased heart rate and portal venous pressure significantly and did not alter arterial pressure. Propranolol decreased fractional hepatic blood flow significantly in rats with hepatic artery ligature, but did not change hepatic blood flow in rats with portal vein stenosis or in sham-operated rats. 3. We conclude therefore that: (a) propranolol decreases portal venous pressure in rats; (b) this decrease in portal venous pressure results in a reduction in portal blood flow which is related, in part, to a reduction in cardiac output; (c) propranolol does not alter hepatic blood flow in normal rats or in rats with portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083761     DOI: 10.1042/cs0630029

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.

Authors:  C W Kong; C S Lay; Y T Tsai; S D Lee; K H Lai; K J Lo; B N Chiang
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

2.  Medical treatment of portal hypertension and oesophageal varices.

Authors:  P Cales; A Braillon; D Lebrec
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

3.  Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.

Authors:  C Merkel; D Sacerdoti; G F Finucci; R Zuin; G Bazzerla; M Bolognesi; A Gatta
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

4.  Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.

Authors:  S K Sarin; R J Groszmann; P G Mosca; M Rojkind; M J Stadecker; R Bhatnagar; A Reuben; Y Dayal
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  Influence of cancer cachexia on drug liver metabolism and renal elimination in rats.

Authors:  Katja Cvan Trobec; Mojca Kerec Kos; Jurij Trontelj; Iztok Grabnar; Anika Tschirner; Sandra Palus; Stefan D Anker; Jochen Springer; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-03       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.